Fast Relief of Migraine Pain Achieved with New OptiNose Migraine Treatment …

Published November 15, 2012

Fast Relief of Migraine Pain Achieved with New OptiNose Migraine Treatment …

Filed under: drug treatment centers in pennsylvania

YARDLEY, Pa., Nov. 14, 2012 — /PRNewswire/ — OptiNose US Inc. today announced that the phase III TARGET study successfully met its primary endpoint, finding the new 16 mg OptiNose sumatriptan product provided headache relief for 68% of patients with …
Read more on Sacramento Bee

Novel Drug Boosts Anti-VEGF Effects in AMD

Filed under: drug treatment centers in pennsylvania

A total of 449 patients were randomized to one of three treatment groups: 1.5 mg of Fovista plus ranibizumab, 0.3 mg of Fovista plus ranibizumab, or 0.5 mg ranibizumab monotherapy. For the combination therapy groups, two injections were given half an …
Read more on MedPage Today